Showing results (141-150 of 194) with videos related to
Sort By:
Pageof 20
Journal of Acquired Immune Deficiency Syndromes|March 1, 1993
HIV-related ocular microangiopathic syndrome and cognitive functioningS A Geier, C Perro, V Klauss, et al.The Netherlands Journal of Medicine|June 30, 2012
Severe pulmonary manifestation of leptospirosisH J F Helmerhorst, E N van Tol, P R Tuinman, et al.Dermatology (Basel, Switzerland)|January 9, 2001
Bacillary angiomatosis in HIV-infected patients--an epidemiological and clinical studyA Plettenberg, T Lorenzen, B T Burtsche, et al.Antiviral Therapy|May 1, 2001
Single dose, dose-escalating trial with fozivudine tidoxil (BM 21.1290)J R Bogner, D Boerner, A Mühlhöfer, et al.Tropical Medicine & International Health : TM & IH|April 11, 2012
Scale-up of TB and HIV programme collaborative activities in Zambia - a 10-year reviewN Kapata, P Chanda-Kapata, M P Grobusch, et al.Italian Journal of Gastroenterology and Hepatology|July 24, 1998
Natural beta interferon in acute type-C hepatitis patients: a randomized controlled trialG Calleri, P Colombatto, M Gozzelino, et al.The Journal of Infectious Diseases|January 7, 2011
Clinical outcome of HIV-infected patients with discordant virological and immunological response to antiretroviral therapyA Zoufaly, M an der Heiden, C Kollan, et al.Journal of Viral Hepatitis|February 22, 2005
Treatment of acute hepatitis C infection in HIV-infected patients: a retrospective analysis of eleven casesM Vogel, B Bieniek, H Jessen, et al.HIV Medicine|January 18, 2008
Regional differences in the risk of triple class failure in European patients starting combination antiretroviral therapy after 1 January 1999A Mocroft, A Horban, B Clotet, et al.European Journal of Medical Research|June 18, 2010
Cost impact of prospective HLA-B*5701-screening prior to abacavir/lamivudine fixed dose combination use in GermanyEva Wolf, M Blankenburg, J R Bogner, et al.Pageof 20